Ignite Creation Date:
2024-05-06 @ 3:46 AM
Last Modification Date:
2024-10-26 @ 11:38 AM
Study NCT ID:
NCT02367638
Status:
COMPLETED
Last Update Posted:
2017-04-27
First Post:
2015-02-12
Brief Title:
Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-03
Start Date Type:
None
Primary Completion Date:
2015-07
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2015-02-12
First Submit QC Date:
February 12 2015
Study First Post Date:
2015-02-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-25
Last Update Post Date:
2017-04-27
Last Update Post Date Type:
ACTUAL